Topical bioavailability of triamcinolone acetonide: Effect of occlusion

Skin Pharmacology and Physiology

Volumn 20, Issue 1, 2006, Pages 50-56

  Pellanda, C ^a   Strub, C ^a   Figueiredo, V ^a   Rufli, T ^a   Imanidis, G ^b   Surber, C ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Occlusion; Reservoir; Tape stripping; Topical bioavailability; Triamcinolone acetonide

Indexed keywords

TRIAMCINOLONE ACETONIDE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG PENETRATION; FEMALE; FOREARM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; OCCLUSION; PRIORITY JOURNAL; SKIN EXAMINATION; STRATUM CORNEUM; ULTRAVIOLET SPECTROSCOPY;

ADMINISTRATION, TOPICAL; ADULT; BANDAGES; BIOLOGICAL AVAILABILITY; FEMALE; HUMANS; MALE; SKIN ABSORPTION; TRIAMCINOLONE ACETONIDE;

EID: 33845744812     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096172     Document Type: Article

References (25)

1. Zhai H, Maibach HI: Occlusion vs skin barrier function. Skin Res Technol 2002;8:1-6.
2. Norlen L, Emilson A, Forslind B: Stratum corneum swelling: biophysical and computer-assisted quantitative assessments. Arch Dermatol Res 1997;289:506-513.
3. Bouwstra JA, de Graaff A, Gooris GS, Nijsse J, Wiechers JW, van Aelst AC: Water distribution and related morphology in human stratum corneum at different hydration levels. J Invest Dermatol 2003;120:750-758.
4. Matsumura H, Oka K, Umekage K, Akita H, Kawai J, Kitazawa Y, Suda S, Tsubota K, Ninomiya Y, Hirai H, et al: Effect of occlusion on human skin. Contact Dermatitis 1995;33:231-235.
5. Vickers CF: Existence of reservoir in the stratum corneum: experimental proof. Arch Dermatol 1963;88:20-23.
6. Bucks DA, McMaster JR, Maibach HI, Guy RH: Bioavailability of topically administered steroids: a 'mass balance' technique. J Invest Dermatol 1988;91:29-33.
7. Bucks DA, Maibach HI, Guy RH: Occlusion does not uniformly enhance penetration in vivo; in Bronaugh RL, Maibach HI (eds): Percutaneous Absorption: Drugs - Cosmetics - Mechanisms - Methodology. Boca Raton, Taylor & Francis, 2005, pp 65-83.
8. Treffel P, Muret P, Muret-D'Aniello P, Coumes-Marquet S, Agache P: Effect of occlusion on in vitro percutaneous absorption of two compounds with different physicochemical properties. Skin Pharmacol 1992;5:108-113.
9. Cross SE, Roberts MS: The effect of occlusion on epidermal penetration of parabens from a commercial allergy test ointment, acetone and ethanol vehicles. J Invest Dermatol 2000;115:914-918.
10. PIC-Leitfaden einer guten Herstellungspraxis für pharmazeutische Produkte, ed 3, Zürich, Kantonale Heilmittelkontrolle Zürich, 2004.
11. Surber C, Schwarb FP, Smith EW: Tape-stripping technique; in Bronaugh RL, Maibach HI (eds): Percutaneous Absorption: Drugs - Cosmetics - Mechanisms - Methodology. Boca Raton, Taylor & Francis, 2005, pp 399-410.
12. Weigmann HJ, Lindemann U, Antoniou C, Tsikrikas GN, Stratigos AI, Katsambas A, Sterry W, Lademann J: UV/VIS absorbance allows rapid, accurate, and reproducible mass determination of corneocytes removed by tape stripping. Skin Pharmacol Appl Skin Physiol 2003;16:217-227.
13. ICH: Harmonised tripartite guideline Q2(R1) - Validation of analytical procedures: text and methodology. 1996. Available online at www.ich.org.
14. Trampisch HJ, Windeler J, Ehle B, Lange S: Trennschärfe statistischer Tests; in Trampisch HJ, Windeler J (eds): Medizinische Statistik. Berlin, Springer, 2000, pp 223-233.
15. EMEA: Note for guidance on the investigation of bioavailability and bioequivalence. London, Committee for Proprietary Medicinal Products, 2001.
16. Jacobi U, Meykadeh N, Sterry W, Lademann J: Effect of the vehicle on the amount of stratum corneum removed by tape stripping. J Dtsch Dermatol Ges 2003;1:884-889.
17. Weigmann HJ, Jacobi U, Antoniou C, Tsikrikas GN, Wendel V, Rapp C, Gers-Barlag H, Sterry W, Lademann J: Determination of penetration profiles of topically applied substances by means of tape stripping and optical spectroscopy: UV filter substance in sunscreens. J Biomed Opt 2005;10:140091-140097.
18. Melendres JL, Bucks DA, Camel E, Wester RC, Maibach HI: In vivo percutaneous absorption of hydrocortisone: multiple-application dosing in man. Pharm Res 1992;9:1164-1167.
19. Bucks DA, Maibach HI, Guy RH: Percutaneous absorption of steroids: effect of repeated application. J Pharm Sci 1985;74:1337-1339.
20. Wester RC, Noonan PK, Maibach HI: Frequency of application on percutaneous absorption of hydrocortisone. Arch Dermatol 1977;113:620-622.
21. Scheuplein RJ, Ross LW: Mechanism of percutaneous absorption. 5. Percutaneous absorption of solvent deposited solids. J Invest Dermatol 1974;62:353-360.
22. Anissimov YG, Roberts MS: Diffusion modeling of percutaneous absorption kinetics. 2. Finite vehicle volume and solvent deposited solids. J Pharm Sci 2001;90:504-520.
23. Agner T, Serup J: Time course of occlusive effects on skin evaluated by measurement of transepidermal water loss (TEWL), including patch tests with sodium lauryl sulphate and water. Contact Dermatitis 1993;28:6-9.
24. Carr RD, Wieland RG: Corticosteroid reservoir in the stratum corneum. Arch Dermatol 1966;94:81-84.
25. McKenzie AW, Stoughton RB: Method for comparing percutaneous absorption of steroids. Arch Dermatol 1962;86:608-610.